Here are four insights:
1. DTRAX devices and instruments are designed to increase procedural efficiency, improve clinical outcomes, minimize complications and reduce recovery time.
2. In total, over 7,000 procedures using DTRAX devices and instruments have been used.
3. The company plans to submit the prosthesis list in August 2017 for inclusion into the market in early 2018.
4. Providence Medical Technology specializes in solutions for cervical spinal conditions. The company is a pioneer for tissue sparing approaches to posterior cervical fusions.
More articles on devices and implants:
Global bone growth stimulator market to hit $3.9B by 2025
ReNetX Bio initiates financing round for spinal cord injury technology trail: 7 highlights
Tissue Regenix proposes acquisition of CellRight Technologies: 4 notes
